PROFILE OF THE WEEK: AMERICAN HOME PRODUCTS

Published on .

In the last few months, American Home Products Corp. has been a takeover target of SmithKline Beecham and Glaxo Wellcome, but both potential mergers quickly fell through.

AHP's prescription antidepressant Effexor has achieved rapid growth, its giant Premarin hormone therapy has continued strong sales and over-the-counter Advil has enjoyed modest sales gains. Still, AHP suffered from questions about the safety of its prescription obesity treatment, Redux, that resulted in its removal from the market.

In this article:
Most Popular